Geographic Atrophy Market Size: Epidemiology, Growth, Scope, Structure, Opportunity and Forecast till (2023-2033)

The newly published report by IMARC Group, titled, ”Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the geographic atrophy market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends.

Geographic atrophy represents an advanced form of dry age-related macular degeneration that affects the retina, a part of the eye that sends information to the brain to enable sight. In this stage, the damage is so severe that it causes blind spots in the central vision of the patient. The common symptoms experienced by patients are central vision loss, difficulty in low-light conditions, and trouble seeing colors. An ophthalmologist can identify geographic atrophy using retinal imaging and a dilated examination.

Request a Free Sample Report: https://www.imarcgroup.com/geographic-atrophy-market/requestsample

The growing prevalence of retinal disorders and the expanding geriatric population are among the key factors stimulating the geographic atrophy market. Moreover, the increasing incidences of obesity and cardiovascular diseases (CVDs), on account of changing dietary patterns, sedentary lifestyles, and unhealthy habits, such as smoking, are acting as significant growth-inducing factors.

Besides this, the rising usage of smartphones, laptops, televisions, etc., leading to prolonged and excessive screen time, is positively influencing the global market. Furthermore, the introduction of retinal gene therapies, which involve injecting adeno-associated virus (AAV) into the body to prevent the development of abnormal blood vessels, is also propelling the market growth.

Apart from this, the widespread adoption of autofluorescence imaging technology to visualize the retinal pigment epithelium (RPE) to assess the progression rate of the disease is further fueling the global market. Additionally, the inflating investments by various key players in developing imaging technologies, which will contribute to understanding the genesis and pathophysiological mechanisms of geographic atrophy, are also driving the market growth.

In addition to this, the extensive R&D activities for launching innovative and effective drugs and the increasing expenditure on healthcare to facilitate access to affordable treatment options are anticipated to fuel the geographic atrophy market over the forecasted period.

Report Period:

Base Year: 2022

Historical Period: 2017-2022

Market Forecast: 2023-2033

Countries Included:

United States

Germany

France

United Kingdom

Italy

Spain

Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario

Historical, current, and future performance of the geographic atrophy market

Historical, current, and future performance of various therapeutic categories in the market

Sales of various drugs across the geographic atrophy market

Reimbursement scenario in the market

In-market and pipeline drugs

In-Market Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/geographic-atrophy-market

Key Questions Answered in this Report:

How has the geographic atrophy market performed so far and how will it perform in the coming years?

What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?

What was the country-wise size of the geographic atrophy market across the seven major markets in 2022 and what will it look like in 2033?

What is the growth rate of the geographic atrophy market across the seven major markets and what will be the expected growth over the next ten years?

What are the key unmet needs in the market?

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800